POET Technologies shares are currently in the focus of investors. That’s why the paper is a plaything of extreme market movements.
• POET Technologies shares show extreme swings
• Agreement concluded with Lumilens
• Corporate action of $400 million
The POET Technologies share, which is listed on the NASDAQ, increased by a remarkable 39 percent over the month and has even increased by around 124.5 percent since the beginning of the year. But yesterday, Monday, the price fell by 11.02 percent to 14.21 US dollars.
NASDAQ trading on Tuesday continued to decline: at times the stock lost 11.75 percent to $12.56.
Lumilens agreement comes into focus
POET Technologies is seeking to further commercialize its optical interposer technology and has entered into a strategic development and supply agreement with Lumilens for photonic solutions in AI data centers. The focus is on a so-called “Electrical-Optical Interposer” (EOI), which is intended to integrate electronic and optical components at the wafer level. According to the company, the aim of the collaboration is to develop more powerful and cost-efficient optical connections for AI infrastructures.
As POET Technologies further announced, Lumilens has placed an initial order worth $50 million as part of the agreement. Over a period of five years, the total contract volume could grow to more than $500 million, according to the statement. Markets viewed the agreement with Lumilens announced on May 15 as a positive operational signal.
Corporate action of $400 million
However, a capital increase is now weighing on the mood. The company placed a registered direct offering with gross proceeds of approximately $400 million by issuing approximately 19.05 million common shares and accompanying warrants to an institutional investor. According to the company’s announcement, the issue price was $21.00 per unit, above the 52-week high of $20.81 reached in mid-May. In addition, warrants with a term of three years were issued, which can be redeemed at an exercise price of $26.25 per share.
According to POET Technologies, the funds from the financing will primarily be used to implement the growth strategy. This includes expanding manufacturing capacity, investing in research and development, and scaling activities in the area of optical light sources and modules for AI and data center applications.
In addition, the company plans to use the funds for possible acquisitions and general corporate financing. The aim is to accelerate the industrial scaling of the Photonic Interconnect platform and further expand the position in the market for AI infrastructure.
Such capital measures often cause nervousness on the stock market as existing shareholders fear that their shares will be diluted. The share reacted correspondingly volatile to the report.
What this means for private investors
For private investors, POET Technologies remains a speculative technology stock with correspondingly high risks. The share is currently making operational progress alongside concerns about financing and possible dilution effects. Investors should therefore pay particular attention to how the funds from the capital measure are used and whether the cooperation with Lumilens leads to further commercial progress. Because of its high volatility, the share remains particularly suitable for investors who are willing to take risks.
Thomas Zoller, Martina Köhler, Benedict Kurschat, editorial team finanzen.net
Selected leverage products on POET Technologies
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on POET Technologies
The leverage must be between 2 and 20
Advertising